col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


130 Ergebisse       Seite 1

 [1] 
Elsevier: Drug and Alcohol Dependence
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―02 Persistence of the Modifications in the Delivery of Opioid Agonist Therapy during the Pandemic Negar Shavandi, Julia Saragosa, Francesca Di Paola, Bruna Brands, Maria Zhang, Beth Sproule
2 [GO] 2025―Feb―02 Association of Telemedicine Policies Implemented during the COVID-19 Pandemic With Receipt of Substance Use Disorder Treatment Kayla Tormohlen, Matthew Eisenberg, Alex McCourt, Jiani Yu, Emma McGinty
3 [GO] 2025―Feb―02 Mental Health and Tobacco Use Initiation Among a Nationally Representative Sample of Black Adolescents During the COVID-19 Pandemic Wynta Alexander, Adriana Espinosa, Lesia M. Ruglass, Fiona N. Conway, Christine Sheffer
4 [GO] 2025―Feb―02 Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic Sugy Choi, Leah L. Habersham, Brooke S. West
5 [GO] 2025―Feb―02 Treatment Delivery and Prescribing Medications for Opioid Use Disorder Among American Indian and Alaska Native Adults during the Height of the COVID-19 Pandemic Maia McCluskey, Kait Hirchak, Kelsey Bajet, Meenakshi Richardson, Raquel Shaffer, Beverly Keyes, et al. (+5)
6 [GO] 2025―Feb―02 Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic Sugy Choi, Leah L. Habersham, Brooke S. West
7 [GO] 2025―Feb―02 Adverse Childhood Experiences and Adolescent Substance Use After the COVID-19 Pandemic Sunny Shin, Casey Burton, Casey Corso
8 [GO] 2025―Feb―02 Access to and Satisfaction With Telemedicine Addiction Care during the COVID-19 Pandemic David Reading, Paxton Bach, JinCheol Choi, Kora DeBeck, Thomas Kerr, Kanna Hayashi
9 [GO] 2025―Feb―02 Perceived Impact of COVID-19 on Substance Use Among People Who Use Opioids (PWUO) in the Southeastern United States Skye Holm, Tanja Laschober, Susan Tross, Mary Hatch
10 [GO] 2025―Feb―02 Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder Morgan Ford, Anh Nguyen, Ingrid Binswanger, Komal Narwaney, Jason Lyons, Deborah Rinehart, et al. (+2)
11 [GO] 2025―Feb―02 Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study Dallas Swendeman, Melvin Rico, Whitney Akabike, Leticia Cazares, Geoffrey Curran, Lillian Gelberg
12 [GO] 2025―Feb―02 Examining the Role of Emergency Housing in Safer Supply Prescription Access in British Columbia Amidst Overlapping COVID-19 and Overdose Public Health Emergencies: A Qualitative Study Sylvia Parusel, Taylor Fleming, Samara Mayer, Manal Mansoor, Andrew Ivsins, Jade Boyd, Ryan McNeil
13 [GO] 2024―Aug―14 ALCOHOL USE, DRIVING, AND IMPAIRED DRIVING AMONG RECENT LATINO IMMIGRANTS TO MIAMI/DADE CO. (FL) BEFORE, DURING, AND AFTER THE COVID-19 LOCKDOWN E Romano, M Sanchez
14 [GO] 2024―Aug―14 SOCIAL IMPACTS OF THE COVID-19 PANDEMIC ON WOMEN'S HEALTH J. Murillo
15 [GO] 2024―Aug―14 COVID-19 VACCINE ACCEPTANCE IN A COMMUNITY SAMPLE OF ADULTS: CONVIDA EN GUACHUPITA, DOMINICAN REPUBLIC P Rojas, W Wang, M Miric, Q Wanda, O Novoa, A Caban-Martinez, et al. (+5)
16 [GO] 2024―Aug―14 PANDEMIC STRESS AND ADVERSE MENTAL HEALTH OUTCOMES AMONG RECENT LATINO/A IMMIGRANTS: EXPLORING EFFECTIVE COPING STRATEGIES A Penn, E Romano, G Ravelo, M De La Rosa, M Sanchez
17 [GO] 2024―Jul―12 SYMPOSIUM: THE INTERSECTION OF COVID-19 AND SUBSTANCE USE DISORDERS Carlos Blanco, Leonardo Angelone
18 [GO] 2024―Jul―12 ACCESS TO NO-COST PHARMACEUTICAL ALTERNATIVES TO ILLICIT DRUGS DURING INTERSECTING COVID-19 AND OVERDOSE HEALTH EMERGENCIES IN BRITISH COLUMBIA, CANADA: A QUALITATIVE STUDY Ryan McNeil, Taylor Fleming, Samara Mayer, Sylvia Parusel, Andrew Ivsins, Jade Boyd
19 [GO] 2024―Jul―12 Persistent Anxiety is Associated With Reporting At-Risk Drinking During COVID-19 Among Women in a Community Setting Alyssa Berger, Linda Cottler
20 [GO] 2024―Jul―12 Comparing mHealth Use and Acceptability in Individuals Engaged in Treatment for Substance Use Disorders Prior to and After the Start of COVID-19 Emily A. Levine, Hannah Shapiro, R. Kathryn McHugh, Roger D. Weiss, Shelly F. Greenfield, Dawn E. Sugarman
21 [GO] 2024―Jul―12 MONITORING ONLINE ILLICIT DRUG MARKET DURING THE COVID-19 David Otiashvili, Tamar Mgebrishvili, Ada Beselia, Irma Kirtadze
22 [GO] 2024―Jul―12 Applying Theory of Planned Behavior to Predict Online Addiction Treatment Intention During COVID-19 Hagit Bonny-Noach, Dudi Gold, Ariel Caduri
23 [GO] 2024―Jul―12 Scaling up Opioid Agonist Therapies in Ukraine Before the War: Implementation Factors Related to Disruptions From Legislative Reform and COVID-19 Lynn Madden, Roman Ivasiy, Maxim Polonsky, Scott Farnum, Samy Galvez, Anna Meteliuk, et al. (+2)
24 [GO] 2024―Jul―12 Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study Denise Vidot, Amrit Baral, Bria-Necole Diggs, Sitara Weerakoon, Moudou Baquai, Ramessu Iyi, et al. (+2)
25 [GO] 2024―Jul―12 High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study Denise Vidot, Bria-Necole Diggs, Amrit Baral, Michaela Larson, Sitara Weerakoon, Moudou Baquai, et al. (+4)
26 [GO] 2024―Jul―12 Age and Pandemic-Related Stress Among Cannabis Consumers in First Year of COVID-19 Pandemic: Preliminary Results From the COVID-19 Cannabis Health Study Layan Ibrahim, Marvin Reid, Nicole O'Dell, Audrey Harkness, Denise Vidot
27 [GO] 2024―Jul―12 Chronic Disease Symptoms Self-Managed With Cannabis During the COVID-19 Pandemic: Results From the COVID-19 Cannabis Health Study Nicole O'Dell, Marvin Reid, Jessica Islam, Marlene Camacho-Rivera, Denise Vidot
28 [GO] 2024―Jul―12 Gender, Mental Health, and Cannabis Use Amongst Students in the United States During the Pandemic: Results From the COVID-19 Cannabis Health Study Ana Borja, Marvin Reid, Layan Ibrahim, Nicole O'Dell, Deanna Uddin, Denise Vidot
29 [GO] 2024―Jul―12 Cannabis Use and Mental Health Coping Behavior Among Minority Women During the COVID-19 Pandemic: Results From the COVID-19 Cannabis Health Study Bria-Necole Diggs, Ranya Marrakchi El Fellah, Cynthia Lebron, Sitara Weerakoon, Sarah Messiah, Denise Vidot
30 [GO] 2024―Jul―12 RELATIONSHIP BETWEEN INCREASED POLYSUBSTANCE USE, ANXIETY, AND STRESS DURING THE COVID-19 PANDEMIC: RESULTS FROM THE COVID-19 CANNABIS HEALTH STUDY Sitara Weerakoon, Bria-Necole Diggs, Sarah Messiah, Michelle Weiner, Denise Vidot
31 [GO] 2024―Jul―12 Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic Kerry Flannagan, Marushka Silveira, Colm Everard, Heather Kimmel, Satoko Kuramoto-Crawford, Daniela Marshall, et al. (+2)
32 [GO] 2024―Jul―12 A Prospective Study on Changes in Alcohol, Cannabis, and Tobacco Use From Before to During the COVID-19 Pandemic J. Megan Ross, Jesse Hinckley, Jarrod Ellingson, Stephanie Zellers, Matt McGue, Robin Corley, et al. (+6)
33 [GO] 2024―Jul―12 Opioid Agonist Treatment Modifications During COVID-19 Pandemic Beth Sproule, Jessica Stovel, Julia Saragosa, Helen Huynh, Francesca Di Paola, Bruna Brands, Maria Zhang
34 [GO] 2024―Jul―12 Evaluating Changes in Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder Before and During the COVID-19 Pandemic Anh Nguyen, Ingrid Binswanger, Komal Narwaney, Stanley Xu, David McClure, Deborah Rinehart, Jason Glanz
35 [GO] 2024―Jul―12 Development of a Community-Based Wastewater Surveillance System to Measure Opioid, Stimulant and Medications for Opioid Use Disorder in the COVID-19 Pandemic Peter Chai, Gordon Getzinger, Joji Suzuki, Alex Buben, Matthew Boyce, Kait Hess, et al. (+3)
36 [GO] 2024―Jul―12 COMING OUT TO TREATMENT: CHARACTERIZING EXPERIENCES OF SEXUAL AND GENDER MINORITIZED INDIVIDUALS IN SUBSTANCE USE DISORDER TREATMENT BEFORE AND DURING THE COVID-19 PANDEMIC Jaclyn Sadicario, Dace Svikis
37 [GO] 2024―Jul―12 COVID-19 Vaccination and HIV Transmission Among Persons who Inject Drugs During the First Two Years of the COVID-19 Pandemic in New York City Don Des Jarlais, Chenziheng (Allen) Weng, Jonathan Feelemyer, Courtney McKnight
38 [GO] 2024―Jul―12 Non-Fatal Drug Overdose Among Persons who Inject Drugs During First Two Years of the COVID-19 Pandemic in New York City: Prevalence, Risk Jonathan Feelemyer, Chenziheng (Allen) Weng, Courtney McKnight, Don Des Jarlais
39 [GO] 2024―Jul―12 Initiations of Safer Supply Hydromorphone Increased During the COVID-19 Pandemic in Ontario: An Interrupted Time-Series Analysis Samantha Young, Tara Gomes, Gillian Kolla, Daniel McCormack, Zoë Dodd, Janet Raboud, Ahmed Bayoumi
40 [GO] 2024―Jul―12 Co-Occurrence of Gaming Disorder and Drug Dependence in People who Use Stimulants During the Era of COVID-19 Pandemic in Taiwan Tony Szu-Hsien Lee, Ming-Chyi Huang, Lian-Yu Chen, Kuen-Hong Wu, Su-Chen Fang, Cheng-Yi Huang, et al. (+6)
41 [GO] 2024―Jul―12 Exploring the Impact of the COVID-19 Pandemic on MOUD Retention in a Sample of Rural Primary Care Patients Stacy Calhoun, Huiying Guo, Zhe Fei, Laura-Mae Baldwin, Allison Ober, Megan Black, et al. (+7)
42 [GO] 2024―Jul―12 Substance Use, Psychiatric Disorders, and the COVID-19 Vaccine: A Quality Improvement Project Zoe Karavolis, Emily Thacker, Maureen Reynolds, Ralph Tarter, Antoine Douaihy
43 [GO] 2024―Jul―12 Rapid Jail-Based Implementation of Overdose Education and Naloxone Distribution (OEND) in Response to the COVID-19 Pandemic Carrie Oser, Margaret McGladrey, Marisa Booty, Hilary Surratt, Hannah Knudsen, Patricia Freeman, et al. (+6)
44 [GO] 2024―Jul―12 Care Utilization Among Patients With Stimulant Use Disorder During COVID-19: A National Cohort Study of U.S. Veterans Lewei (Allison) Lin, Madeline Frost, Lan Zhang, Lara Coughlin
45 [GO] 2024―Jul―12 ASSOCIATIONS BETWEEN GEOSOCIAL SEXUAL NETWORKING APP USE AND DRUG USE, PARTNER TYPE, AND SEXUAL BEHAVIORS AMONG SEXUAL MINORITY MEN DURING THE FIRST SHELTER-IN-PLACE ORDER OF THE CORONAVIRUS PANDEMIC IN TEXAS Oralia Loza, Nqobile Nzama, Oscar Beltran, Aliza Norwood, Phillip Schnarrs
46 [GO] 2024―Jul―12 Pandemic Era Changes in Drug Use and Harm Reduction Behavior Among People who Use Drugs in Rural Illinois Alex Rains, Ellen Almirol, Erin Augustine, Kyle Miller, Elizabeth Salisbury-Afshar, Wiley Jenkins, Mai Pho
47 [GO] 2024―Jul―12 CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY Stephanie Nuñez, Lillian Polanco-Roman, Rosario Costas-Muñiz, Tashuna Albritton, Deidre Anglin
48 [GO] 2023―Nov―11 Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic Allison Perry, Katherine Wheeler-Martin, Deborah S. Hasin, Kelly Terlizzi, Zachary L. Mannes, Victoria Jent, et al. (+6)
49 [GO] 2023―Okt―30 Drug Overdose Mortality Rates by Educational Attainment and Sex for Adults Aged 25-64 in the United States Before and During the COVID-19 Pandemic, 2015-2021 Jay J. Xu, Marissa J. Seamans, Joseph R. Friedman
50 [GO] 2023―Sep―20 Impact of COVID-19 on Stimulant Use Disorder Treatment: A National Cohort Study in the Veterans Health Administration Lara N. Coughlin, Madeline C. Frost, Lan Zhang, Lewei (Allison) Lin
51 [GO] 2023―Sep―04 Trends in Self-Reported Non-Fatal Overdose and Patterns of Substance Use Before and During the COVID-19 Pandemic in a Prospective Cohort of Adults who Have Injected Drugs --- Baltimore, Maryland, 2014-2022 Kenneth A. Feder, Eshan U. Patel, Megan Buresh, Gregory D. Kirk, Shruti H. Mehta, Becky L. Genberg
52 [GO] 2023―Mai―17 Alcohol, cannabis, and nicotine use have distinct associations with COVID-19 pandemic-related experiences: An exploratory Bayesian network analysis across two timepoints Santiago Papini, Teresa López-Castro, Margaret Swarbrick, Lynn K. Paul, Damian Stanley, Alexandria Bauer, Denise A. Hien
53 [GO] 2023―Mrz―03 The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs Angel B. Algarin, Samantha Yeager, Thomas L. Patterson, Steffanie A. Strathdee, Alicia Harvey-Vera, Carlos F. Vera, et al. (+4)
54 [GO] 2023―Feb―09 Temporal association of pre-pandemic perceived social support with psychological resilience and mental well-being during the COVID-19 pandemic among people with a history of injection drug use Eshan U. Patel, Jacquie Astemborski, Kenneth A. Feder, Jacqueline E. Rudolph, Abigail Winiker, David W. Sosnowski, et al. (+3)
55 [GO] 2023―Feb―09 Availability of timely methadone treatment in the United States and Canada during COVID-19: a census tract-level analysis☆ Ofer Amram, Leah Rosenkrantz, Solmaz Amiri DDes, Nadine Schuurman, Victoria J Panwala, Paul J. Joudrey
56 [GO] 2022―Nov―24 Telemedicine along the Cascade of Care for Substance Use Disorders during the COVID-19 Pandemic in the United States Chunqing Lin, Huyen Pham, Yuhui Zhu, Sarah E. Clingan, Lewei (Allison) Lin, Sean M. Murphy, et al. (+5)
57 [GO] 2022―Nov―19 Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic Robert A. Kleinman, Marcos Sanches
58 [GO] 2022―Nov―05 Understanding the impact of the COVID-19 pandemic on substance use and HIV Redonna Chandler, Vasundhara Varthakavi
59 [GO] 2022―Nov―01 The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study Nicholas A. Livingston, Michael Davenport, Michael Head, Rachel Henke, Lavonia Smith LeBeau, Teresa B. Gibson, et al. (+12)
60 [GO] 2022―Okt―06 Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium L King, K Hayashi, B Genberg, J Choi, K DeBeck, G Kirk, et al. (+10)
61 [GO] 2022―Sep―15 Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada Soroush Moallef, Becky L. Genberg, Kanna Hayashi, Shruti H. Mehta, Gregory D. Kirk, JinCheol Choi, et al. (+10)
62 [GO] 2022―Sep―06 Use of COVID-19 Testing in the First Year of the COVID-19 Pandemic Among Cohorts of People at the Intersection of Drugs Use and HIV Pamina M. Gorbach, Alison D. Rosen, Richard Moore, Steve Shoptaw, Brian Mustanski, Shruti H. Mehta, et al. (+9)
63 [GO] 2022―Sep―06 Person-centered patterns of substance use during the COVID-19 pandemic and their associations with COVID-related impacts on health and personal finances in young Black and White women Tammy Chung, Carolyn Sartor, Alison E. Hipwell, Ashley Grosso, Yanping Jiang
64 [GO] 2022―Aug―19 Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemic David Adzrago, Elizabeth O. Obekpa, Tiffany A. Suragh, Evit R. John, Paul G. Yeh, Kathryn R. Gallardo, J. Michael Wilkerson
65 [GO] 2022―Jul―14 Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic Don Des Jarlais, Georgiy Bobashev, Jonathan Feelemyer, Courtney McKnight
66 [GO] 2022―Jun―24 Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada Kenneth A. Feder, JinCheol Choi, Catherine Schluth, Kanna Hayashi, Kora DeBeck, Michael-John Milloy, et al. (+11)
67 [GO] 2022―Apr―26 Factors Associated with Perceived Decline in the Quality of Drugs During the COVID-19 pandemic: Evidence from Community-Recruited Cohorts of People Who Use Drugs in Vancouver, Canada Erica McAdam, Kanna Hayashi, Huiru Dong, Zishan Cui, Kali-olt Sedgemore, Paul Dietze, et al. (+4)
68 [GO] 2022―Apr―14 Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis Ria Garg, Sophie A. Kitchen, Siyu Men, Tonya J. Campbell, Nikki Bozinoff, Mina Tadrous, et al. (+5)
69 [GO] 2022―Apr―07 Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness Thomas D. Brothers, Malcolm Leaman, Matthew Bonn, Dan Lewer, Jacqueline Atkinson, John Fraser, et al. (+9)
70 [GO] 2022―Mrz―21 Binge drinking in Japan during the COVID-19 pandemic: prevalence, correlates and association with preventive behaviors Andrew Stickley, Aya Shirama, Takamu Inagawa, Tomiki Sumiyoshi
71 [GO] 2022―Mrz―03 The relationship of alcohol and other drug use during the COVID-19 Pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts Jarratt D. Pytell, Nicola M. Shen, Jeanne C. Keruly, Catherine R. Lesko, Bryan Lau, Anthony T. Fojo, et al. (+10)
72 [GO] 2022―Mrz―03 Substance Use Disorders and COVID-19: an analysis of nation-wide Veterans Health Administration electronic health records Deborah S. Hasin, David S. Fink, Mark Olfson, Andrew J. Saxon, Carol Malte, Katherine M. Keyes, et al. (+9)
73 [GO] 2022―Feb―12 COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts Catherine R. Lesko, Jeanne C. Keruly, Richard D. Moore, Nicola M. Shen, Jarratt D. Pytell, Bryan Lau, et al. (+10)
74 [GO] 2022―Feb―02 Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States Samantha G. Auty, Kevin N. Griffith
75 [GO] 2022―Jan―31 Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study Kirsten M.A. Trayner, Andrew McAuley, Norah E. Palmateer, Alan Yeung, David J. Goldberg, Megan Glancy, et al. (+12)
76 [GO] 2022―Jan―20 Harm Reduction and Health Services provided by Syringe Services Programs in 2019 and subsequent impact of COVID-19 on Services in 2020 Czarina N. Behrends, Xinlin Lu, Grace J. Corry, Paul LaKosky, Stephanie M. Prohaska, Sara N Glick, et al. (+4)
77 [GO] 2022―Jan―11 Risk Factors for COVID-19 among Persons with Substance Use Disorder (PWSUD) with Hospital Visits - United States, April 2020 - December 2020 Amy R. Board, Sunkyung Kim, Joohyun Park, Lyna Schieber, Gabrielle F. Miller, Jamison Pike, et al. (+2)
78 [GO] 2022―Jan―11 Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic David Dadiomov, Rebecca Trotzky-Sirr, Andrew Shooshtari, Dima M. Qato
79 [GO] 2022―Jan―10 Trajectories of Alcohol Use and Problems During the COVID-19 Pandemic: The Role of Social Stressors and Drinking Motives for Men and Women Joan S. Tucker, Anthony Rodriguez, Harold D. Green, Michael S. Pollard
80 [GO] 2022―Jan―10 Pharmacists expanded role in providing care for opioid use disorder during COVID-19: A qualitative study exploring pharmacists’ experiences Lisa D. Bishop, Zahava R.S. Rosenberg-Yunger
81 [GO] 2021―Dez―25 Short-term binge drinking, marijuana, and recreational drug use trajectories in a prospective cohort of people living with HIV at the start of COVID-19 mitigation efforts in the United States Steven Meanley, Seul Ki Choi, Azure B. Thompson, Jacquelyn L. Meyers, Gypsyamber D’Souza, Adaora A. Adimora, et al. (+13)
82 [GO] 2021―Dez―24 Examining the impact of social distancing and methamphetamine use on sexual risk and intimate partner violence in sexual and gender minority young adults during the COVID-19 pandemic Casey D. Xavier Hall, Marjan Javanbakht, Chitra Iyer, Cocoa Costales, Julia C. Napolitano, Tony Johnson, et al. (+6)
83 [GO] 2021―Dez―24 HIV, Psychological Resilience, and Substance Misuse During the COVID-19 Pandemic: A Multi-Cohort Study Marianna K. Baum, Javier A. Tamargo, Janet Diaz-Martinez, Ivan Delgado-Enciso, Christina S. Meade, Gregory D. Kirk, et al. (+10)
84 [GO] 2021―Dez―24 Safer In Care: A Pandemic-tested Model of Integrated HIV/OUD Care Ellen F Eaton, Ashutosh Tamhane, Wesli Turner, James L Raper, Michael S Saag, Karen L. Cropsey
85 [GO] 2021―Nov―26 Trends in Pharmacy-Based Dispensing of Buprenorphine, Extended-Release Naltrexone, and Naloxone During the COVID-19 Pandemic by Age and Sex - United States, March 2019 - December 2020 Laura J. Cremer, Amy Board, Gery Guy, Lyna Schieber, Alice Asher, Erin M. Parker
86 [GO] 2021―Nov―26 Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program Robert Harris, Amanda Rosecrans, Meredith Zoltick, Catherine Willman, Ronald Saxton, Margaret Cotterell, et al. (+3)
87 [GO] 2021―Nov―17 Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States Constanza de Dios, Brisa S. Fernandes, Kristine Whalen, Shruti Bandewar, Robert Suchting, Michael F. Weaver, Sudhakar Selvaraj
88 [GO] 2021―Okt―29 Alcohol and other substance use during the COVID-19 pandemic: a systematic review Amanda Roberts, Jim Rogers, Rachael Mason, Aloysius Niroshan Siriwardena, Todd Hogue, Gregory Adam Whitley, Graham R. Law
89 [GO] 2021―Okt―28 Impacts of COVID-19 on cigarette use, smoking behaviors, and tobacco purchasing behaviors Sarah F. Maloney, Madison Combs, Rebecca Lester Scholtes, Megan Underwood, Barbara Kilgalen, Eric K. Soule, Alison B. Breland
90 [GO] 2021―Okt―28 Maintaining Recovery from Alcohol Use Disorder during the COVID-19 Pandemic: The Importance of Recovery Capital Paul A. Gilbert, Loulwa Soweid, Sarah K. Kersten, Grant Brown, Sarah E. Zemore, Nina Mulia, Anne Helene Skinstad
91 [GO] 2021―Sep―24 The Impact of COVID-19 on Opioid Treatment Programs in the United States Lloyd A. Goldsamt, Andrew Rosenblum, Philip Appel, Philip Paris, Nasreen Nazia
92 [GO] 2021―Sep―23 Treatment Provider Perceptions of Take-Home Methadone Regulation Before and During COVID-19 Erin Fanning Madden, Bryson T. Christian, Pooja A. Lagisetty, Brad R. Ray, Sandra H. Sulzer
93 [GO] 2021―Sep―22 The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review Rose A. Schmidt, Rosalie Genois, Jonathan Jin, Daniel Vigo, Jürgen Rehm, Brian Rush
94 [GO] 2021―Sep―10 Reply to: Decrease in prevalence but increase in frequency of non-marijuana drug use following the onset of the COVID-19 pandemic in a large cohort of young men who have sex with men and young transgender women Nathan Mitchell
95 [GO] 2021―Sep―02 Gender, Employment, and Continuous Pandemic as Predictors of Alcohol and Drug Consumption during the COVID-19 Inna Levy, Keren Cohen-Louck, Hagit Bonny-Noach
96 [GO] 2021―Sep―02 Opioid-related deaths before and after COVID-19 stay-at-home orders in Los Angeles County Marcella Kelley, Jonathan Lucas, Emily Stewart, Dana Goldman, Jason N. Doctor
97 [GO] 2021―Sep―01 Risk factors for elevations in substance use and consequences during the COVID-19 pandemic among sexual and gender minorities assigned female at birth Christina Dyar, Ethan Morgan, Debra Kaysen, Michael E. Newcomb, Brian Mustanski
98 [GO] 2021―Aug―28 The impact of the National Stay-at-Home Order on Emergency Department Visits for Suspected Opioid Overdose During the First Wave of the COVID-19 Pandemic Elisabeth D. Root, Svetla Slavova, Marc LaRochelle, Daniel J. Feaster, Jennifer Villani, Jolene Defiore-Hyrmer, et al. (+8)
99 [GO] 2021―Aug―28 The relationship between COVID-19-specific health risk beliefs and the motivation to quit smoking: a UK-based survey Chris R.H. Brown
100 [GO] 2021―Aug―27 A Randomized Controlled Trial of a Therapeutic Relational Agent for Reducing Substance Misuse during the COVID-19 Pandemic Judith J. Prochaska, Erin A. Vogel, Amy Chieng, Michael Baiocchi, Dale Dagar Maglalang, Sarah Pajarito, et al. (+3)
101 [GO] 2021―Jul―21 Longitudinal associations with alcohol consumption during the first COVID-19 lockdown: associations with mood, drinking motives, context of drinking, and mental health Patricia Irizar, Andrew Jones, Paul Christiansen, Laura Goodwin, Suzi Gage, Carl Roberts, et al. (+3)
102 [GO] 2021―Jun―30 Sociodemographic changes in emergency department visits due to alcohol during COVID-19 Daniel T. Myran, Nathan Cantor, Michael Pugliese, Tavis Hayes, Robert Talarico, Paul Kurdyak, et al. (+2)
103 [GO] 2021―Jun―24 Adolescent Drug Use Before and During U.S. National COVID-19 Social Distancing Policies Richard Miech, Megan E. Patrick, Katherine Keyes, Patrick M. O’Malley, Lloyd Johnston
104 [GO] 2021―Jun―18 COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs Carmen L. Masson, Caravella McCuistian, Elana Straus, Sania Elahi, Maggie Chen, Valerie A. Gruber, et al. (+2)
105 [GO] 2021―Jun―18 Prevalence, risk and protective factors of alcohol use disorder during the COVID-19 pandemic in U.S. military veterans Peter J. Na, Sonya B. Norman, Brandon Nichte, Melanie L. Hil, Marc I. Rose, Ismene L. Petraki, Robert H. Pietrzak
106 [GO] 2021―Mai―23 Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic Christopher M. Jones, Mamadou M. Diallo, Meena Vythilingam, Joshua G. Schier, Matthew Eisenstat, Wilson M. Compton
107 [GO] 2021―Mai―21 Alcohol and substance use in pregnancy during the COVID-19 pandemic Preeti Kar, Lianne Tomfohr-Madsen, Gerald Giesbrecht, Mercedes Bagshawe, Catherine Lebel
108 [GO] 2021―Mai―21 Change in marijuana use and its associated factors among persons living with HIV (PLWH) during the COVID-19 pandemic: Findings from a prospective cohort Yan Wang, Gladys E. Ibañez, Krishna Vaddiparti, Nichole E. Stetten, Ruba Sajdeya, Eric C. Porges, et al. (+2)
109 [GO] 2021―Apr―13 Decrease in prevalence but increase in frequency of non-marijuana drug use following the onset of the COVID-19 pandemic in a large cohort of young men who have sex with men and young transgender women Patrick Janulis, Michael E. Newcomb, Brian Mustanski
110 [GO] 2021―Mrz―19 A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19 Steffanie A. Strathdee
111 [GO] 2021―Mrz―19 Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic Amanda M. Bunting, David Frank, Joshua Arshonsky, Marie A. Bragg, Samuel R. Friedman, Noa Krawczyk
112 [GO] 2021―Mrz―13 Modifications to the HEALing Communities Study in response to COVID-19 related disruptions Scott T. Walters, Redonna K. Chandler, Thomas Clarke, Nabila El-Bassel, Lashawn M. Glasgow, Rebecca D. Jackson, et al. (+4)
113 [GO] 2021―Mrz―02 Shifts in drug seizures in the United States during the COVID-19 pandemic Joseph J. Palamar, Austin Le, Thomas H. Carr, Linda B. Cottler
114 [GO] 2021―Feb―21 Changes in Alcohol Use Since the Onset of COVID-19 Are Associated With Psychological Distress Among Sexual and Gender Minority University Students in the U.S John P Salerno, Cho-Hee Shrader, Angel B. Algarin, Ji-Young Lee, Jessica N. Fish
115 [GO] 2021―Feb―17 What is associated with the increased frequency of heavy episodic drinking during the COVID-19 pandemic? Data from the PAHO regional web-based survey Juliana Y. Valente, Ivneet Sohi, Rodrigo Garcia Cerde, Maristela G. Monteiro, Zila M. Sanchez
116 [GO] 2021―Feb―16 Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder Brendan P. Jacka, Tim Janssen, Bryan R. Garner, Julia Yermash, Kimberly R. Yap, Elizabeth L. Ball, et al. (+2)
117 [GO] 2021―Feb―16 Self-reported drinking behaviors and observed violation of state-mandated social restriction and alcohol control measures during the COVID-19 pandemic: findings from nationally-representative surveys in Thailand Wit Wichaidit, Monsicha Sittisombut, Sawitri Assanangkornchai, Polathep Vichitkunakorn
118 [GO] 2021―Feb―15 The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland Becky L. Genberg, Jacquie Astemborski, Damani A. Piggott, Tanita Woodson-Adu, Gregory D. Kirk, Shruti H. Mehta
119 [GO] 2021―Feb―15 Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study Dimitra Kale, Aleksandra Herbec, Olga Perski, Sarah E. Jackson, Jamie Brown, Lion Shahab
120 [GO] 2021―Jan―14 Factors associated with drinking behaviour during COVID-19 social distancing and lockdown among adults in the UK Claire Garnett, Sarah Jackson, Melissa Oldham, Jamie Brown, Andrew Steptoe, Daisy Fancourt
121 [GO] 2021―Jan―12 Trust in a COVID-19 Vaccine among People with Substance Use Disorders Alexandra M. Mellis, Braeden C. Kelly, Marc N. Potenza, Jessica N. Hulsey
122 [GO] 2021―Jan―08 Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020 Christopher M. Jones, Gery P. Guy, Amy Board
123 [GO] 2020―Dez―28 Alcohol use and mental health during COVID-19 lockdown: A cross-sectional study in a sample of UK adults Louis Jacob, Lee Smith, Nicola C. Armstrong, Anita Yakkundi, Yvonne Barnett, Laurie Butler, et al. (+8)
124 [GO] 2020―Nov―25 Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic Joanna M. Streck, Sara Kalkhoran, Benjamin Bearnot, Priya S. Gupta, Kelly M. Kalagher, Susan Regan, et al. (+2)
125 [GO] 2020―Okt―17 EXPANDING ACCESSIBILITY: OUTPATIENT INTENSIVE TREATMENT FOR SUBSTANCE USE DISORDER DURING COVID19 PANDEMIC Rebeca Faur, Gustavo Irazoqui, Federico Pavlovsky, Silvia Wikinski
126 [GO] 2020―Sep―18 COVID-19 survey among people who use drugs in three cities in Norway Gabrielle K. Welle-Strand, Svetlana Skurtveit, Thomas Clausen, Christine Sundal, Linn Gjersing
127 [GO] 2020―Sep―02 Strategies to Maintain Persistence of Opioid Agonist Therapy during the Novel Coronavirus Pandemic in Taiwan Cheng-Chan Shih, Yi Chen, Shih-Chieh Shao, Edward Chia-Cheng Lai
128 [GO] 2020―Aug―28 Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A. Tyrel J. Starks, S. Scott Jones, Daniel Sauermilch, Matthew Benedict, Trinae Adebayo, Demetria Cain, Kit N. Simpson
129 [GO] 2020―Jul―10 Signal of Increased Opioid Overdose during COVID-19 from Emergency Medical Services Data Svetla Slavova, Peter Rock, Heather M. Bush, Dana Quesinberry, Sharon L. Walsh
130 [GO] 2020―Mai―08 Overdose and Risk Factors for Severe Acute Respiratory Syndrome Amanda Kathleen Slaunwhite, Wen Qi Gan, Chloe Xavier, Bin Zhao, Jane A Buxton, Roshni Desai
 [1] 

130 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec